UniProt ID | GOGA5_HUMAN | |
---|---|---|
UniProt AC | Q8TBA6 | |
Protein Name | Golgin subfamily A member 5 | |
Gene Name | GOLGA5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 731 | |
Subcellular Localization |
Golgi apparatus membrane Single-pass type IV membrane protein . Found throughout the Golgi, both on cisternae and, at higher abundance, on the tubulo-vesicular structures of the cis-Golgi network. |
|
Protein Description | Involved in maintaining Golgi structure. Stimulates the formation of Golgi stacks and ribbons. Involved in intra-Golgi retrograde transport.. | |
Protein Sequence | MSWFVDLAGKAEDLLNRVDQGAATALSRKDNASNIYSKNTDYTELHQQNTDLIYQTGPKSTYISSAADNIRNQKATILAGTANVKVGSRTPVEASHPVENASVPRPSSHFVRRKKSEPDDELLFDFLNSSQKEPTGRVEIRKEKGKTPVFQSSQTSSVSSVNPSVTTIKTIEENSFGSQTHEAASNSDSSHEGQEESSKENVSSNAACPDHTPTPNDDGKSHELSNLRLENQLLRNEVQSLNQEMASLLQRSKETQEELNKARARVEKWNADHSKSDRMTRGLRAQVDDLTEAVAAKDSQLAVLKVRLQEADQLLSTRTEALEALQSEKSRIMQDQSEGNSLQNQALQTFQERLHEADATLKREQESYKQMQSEFAARLNKVEMERQNLAEAITLAERKYSDEKKRVDELQQQVKLYKLNLESSKQELIDYKQKATRILQSKEKLINSLKEGSGFEGLDSSTASSMELEELRHEKEMQREEIQKLMGQIHQLRSELQDMEAQQVNEAESAREQLQDLHDQIAGQKASKQELETELERLKQEFHYIEEDLYRTKNTLQSRIKDRDEEIQKLRNQLTNKTLSNSSQSELENRLHQLTETLIQKQTMLESLSTEKNSLVFQLERLEQQMNSASGSSSNGSSINMSGIDNGEGTRLRNVPVLFNDTETNLAGMYGKVRKAASSIDQFSIRLGIFLRRYPIARVFVIIYMALLHLWVMIVLLTYTPEMHHDQPYGK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSWFVDLAG ------CCCCCCCCC | 29.26 | 28348404 | |
2 | Acetylation | ------MSWFVDLAG ------CCCCCCCCC | 29.26 | 22223895 | |
33 | Phosphorylation | LSRKDNASNIYSKNT HHCCCCHHHCCCCCC | 29.98 | 27251275 | |
36 | Phosphorylation | KDNASNIYSKNTDYT CCCHHHCCCCCCCHH | 20.17 | 27642862 | |
37 | Phosphorylation | DNASNIYSKNTDYTE CCHHHCCCCCCCHHH | 18.68 | - | |
38 | Ubiquitination | NASNIYSKNTDYTEL CHHHCCCCCCCHHHH | 47.06 | 29967540 | |
40 | Phosphorylation | SNIYSKNTDYTELHQ HHCCCCCCCHHHHHH | 33.83 | 21945579 | |
42 | Phosphorylation | IYSKNTDYTELHQQN CCCCCCCHHHHHHHC | 10.48 | 21945579 | |
43 | Phosphorylation | YSKNTDYTELHQQNT CCCCCCHHHHHHHCC | 34.58 | 21945579 | |
50 | Phosphorylation | TELHQQNTDLIYQTG HHHHHHCCCEEEECC | 28.04 | 21945579 | |
54 | Phosphorylation | QQNTDLIYQTGPKST HHCCCEEEECCCCCH | 13.81 | 21945579 | |
56 | Phosphorylation | NTDLIYQTGPKSTYI CCCEEEECCCCCHHC | 38.18 | 21945579 | |
60 | Phosphorylation | IYQTGPKSTYISSAA EEECCCCCHHCCHHH | 29.58 | 28796482 | |
61 | Phosphorylation | YQTGPKSTYISSAAD EECCCCCHHCCHHHH | 30.88 | 28796482 | |
62 | Phosphorylation | QTGPKSTYISSAADN ECCCCCHHCCHHHHH | 13.09 | 28796482 | |
64 | Phosphorylation | GPKSTYISSAADNIR CCCCHHCCHHHHHHH | 11.96 | - | |
74 | Methylation | ADNIRNQKATILAGT HHHHHHCCCEEEEEC | 51.55 | - | |
81 | Phosphorylation | KATILAGTANVKVGS CCEEEEECCCEEECC | 14.95 | - | |
88 | Phosphorylation | TANVKVGSRTPVEAS CCCEEECCCCCCCCC | 35.65 | 29978859 | |
89 | Methylation | ANVKVGSRTPVEASH CCEEECCCCCCCCCC | 36.80 | - | |
90 | Phosphorylation | NVKVGSRTPVEASHP CEEECCCCCCCCCCC | 33.12 | 25849741 | |
95 | Phosphorylation | SRTPVEASHPVENAS CCCCCCCCCCCCCCC | 18.15 | 26657352 | |
102 | Phosphorylation | SHPVENASVPRPSSH CCCCCCCCCCCCCCH | 44.21 | 26425664 | |
107 | Phosphorylation | NASVPRPSSHFVRRK CCCCCCCCCHHCCCC | 37.41 | 22210691 | |
116 | Phosphorylation | HFVRRKKSEPDDELL HHCCCCCCCCCCHHH | 58.35 | 29255136 | |
129 | Phosphorylation | LLFDFLNSSQKEPTG HHHHHHHCCCCCCCC | 35.97 | 29507054 | |
130 | Phosphorylation | LFDFLNSSQKEPTGR HHHHHHCCCCCCCCC | 44.17 | 25159151 | |
135 | Phosphorylation | NSSQKEPTGRVEIRK HCCCCCCCCCEEEEH | 38.42 | 21712546 | |
147 | Phosphorylation | IRKEKGKTPVFQSSQ EEHHCCCCCEECCCC | 33.10 | 22210691 | |
152 | Phosphorylation | GKTPVFQSSQTSSVS CCCCEECCCCCCCCC | 16.98 | 22210691 | |
153 | Phosphorylation | KTPVFQSSQTSSVSS CCCEECCCCCCCCCC | 27.05 | 22210691 | |
156 | Phosphorylation | VFQSSQTSSVSSVNP EECCCCCCCCCCCCC | 22.55 | 27251275 | |
157 | Phosphorylation | FQSSQTSSVSSVNPS ECCCCCCCCCCCCCC | 29.43 | 27251275 | |
159 | Phosphorylation | SSQTSSVSSVNPSVT CCCCCCCCCCCCCCE | 30.43 | 22210691 | |
160 | Phosphorylation | SQTSSVSSVNPSVTT CCCCCCCCCCCCCEE | 24.61 | 27251275 | |
170 | Phosphorylation | PSVTTIKTIEENSFG CCCEEEEEEECCCCC | 29.75 | 27251275 | |
175 | Phosphorylation | IKTIEENSFGSQTHE EEEEECCCCCHHHCC | 33.97 | 27251275 | |
178 | Phosphorylation | IEENSFGSQTHEAAS EECCCCCHHHCCHHH | 29.87 | 23927012 | |
180 | Phosphorylation | ENSFGSQTHEAASNS CCCCCHHHCCHHHCC | 24.31 | 27251275 | |
185 | Phosphorylation | SQTHEAASNSDSSHE HHHCCHHHCCCCCCC | 43.87 | 23927012 | |
187 | Phosphorylation | THEAASNSDSSHEGQ HCCHHHCCCCCCCCC | 36.05 | 23927012 | |
189 | Phosphorylation | EAASNSDSSHEGQEE CHHHCCCCCCCCCHH | 33.15 | 23927012 | |
190 | Phosphorylation | AASNSDSSHEGQEES HHHCCCCCCCCCHHH | 30.46 | 23927012 | |
197 | Phosphorylation | SHEGQEESSKENVSS CCCCCHHHHHHCCCC | 46.05 | 27251275 | |
198 | Phosphorylation | HEGQEESSKENVSSN CCCCHHHHHHCCCCC | 47.47 | 27251275 | |
203 | Phosphorylation | ESSKENVSSNAACPD HHHHHCCCCCCCCCC | 29.47 | 25159151 | |
204 | Phosphorylation | SSKENVSSNAACPDH HHHHCCCCCCCCCCC | 26.63 | 23312004 | |
212 | Phosphorylation | NAACPDHTPTPNDDG CCCCCCCCCCCCCCC | 35.92 | 28450419 | |
214 | Phosphorylation | ACPDHTPTPNDDGKS CCCCCCCCCCCCCCC | 35.56 | 28450419 | |
225 | Phosphorylation | DGKSHELSNLRLENQ CCCCHHHHHHHHHHH | 30.73 | 24719451 | |
275 | 2-Hydroxyisobutyrylation | KWNADHSKSDRMTRG HHCCCCCHHHHHHHH | 53.61 | - | |
276 | Phosphorylation | WNADHSKSDRMTRGL HCCCCCHHHHHHHHH | 33.20 | 20068231 | |
280 | Phosphorylation | HSKSDRMTRGLRAQV CCHHHHHHHHHHHHH | 23.60 | 20068231 | |
291 | Phosphorylation | RAQVDDLTEAVAAKD HHHHHHHHHHHHHCC | 28.97 | 22210691 | |
299 | Phosphorylation | EAVAAKDSQLAVLKV HHHHHCCCCEEEEEH | 26.79 | 22210691 | |
305 | 2-Hydroxyisobutyrylation | DSQLAVLKVRLQEAD CCCEEEEEHHHHHHH | 20.79 | - | |
337 | Phosphorylation | SRIMQDQSEGNSLQN HHHCCCHHHCCHHHH | 56.62 | 24275569 | |
341 | Phosphorylation | QDQSEGNSLQNQALQ CCHHHCCHHHHHHHH | 42.04 | 27251275 | |
367 | Phosphorylation | TLKREQESYKQMQSE HHHHHHHHHHHHHHH | 37.01 | 28857561 | |
417 | Phosphorylation | LQQQVKLYKLNLESS HHHHHHHHCCCCCCC | 14.01 | - | |
418 | Malonylation | QQQVKLYKLNLESSK HHHHHHHCCCCCCCH | 41.14 | 32601280 | |
444 | Malonylation | RILQSKEKLINSLKE HHHHCHHHHHHHHHC | 59.40 | 26320211 | |
453 | Phosphorylation | INSLKEGSGFEGLDS HHHHHCCCCCCCCCC | 41.21 | 26425664 | |
460 | Phosphorylation | SGFEGLDSSTASSME CCCCCCCCCCCCHHH | 34.33 | 28348404 | |
461 | Phosphorylation | GFEGLDSSTASSMEL CCCCCCCCCCCHHHH | 27.88 | 25849741 | |
462 | Phosphorylation | FEGLDSSTASSMELE CCCCCCCCCCHHHHH | 34.21 | 27251275 | |
464 | Phosphorylation | GLDSSTASSMELEEL CCCCCCCCHHHHHHH | 30.24 | 28985074 | |
465 | Phosphorylation | LDSSTASSMELEELR CCCCCCCHHHHHHHH | 17.51 | 27251275 | |
544 | Phosphorylation | RLKQEFHYIEEDLYR HHHHHHHHHHHHHHH | 18.49 | 25884760 | |
550 | Phosphorylation | HYIEEDLYRTKNTLQ HHHHHHHHHCHHHHH | 28.67 | - | |
558 | Phosphorylation | RTKNTLQSRIKDRDE HCHHHHHHHHCCHHH | 38.80 | 23403867 | |
577 | Ubiquitination | LRNQLTNKTLSNSSQ HHHHHHHCCCCCCCH | 45.68 | 32015554 | |
582 | Phosphorylation | TNKTLSNSSQSELEN HHCCCCCCCHHHHHH | 26.78 | 27251275 | |
583 | Phosphorylation | NKTLSNSSQSELENR HCCCCCCCHHHHHHH | 41.81 | 25159151 | |
585 | Phosphorylation | TLSNSSQSELENRLH CCCCCCHHHHHHHHH | 46.20 | 26471730 | |
601 | Ubiquitination | LTETLIQKQTMLESL HHHHHHHHHHHHHHC | 40.52 | 32015554 | |
612 | Ubiquitination | LESLSTEKNSLVFQL HHHCCCCCCHHHHHH | 52.50 | 32015554 | |
614 | Phosphorylation | SLSTEKNSLVFQLER HCCCCCCHHHHHHHH | 36.66 | 28555341 | |
630 | Phosphorylation | EQQMNSASGSSSNGS HHHHHHCCCCCCCCC | 38.74 | 22210691 | |
632 | Phosphorylation | QMNSASGSSSNGSSI HHHHCCCCCCCCCCC | 28.26 | 27251275 | |
633 | Phosphorylation | MNSASGSSSNGSSIN HHHCCCCCCCCCCCC | 31.20 | 27251275 | |
634 | Phosphorylation | NSASGSSSNGSSINM HHCCCCCCCCCCCCC | 47.08 | 27251275 | |
637 | Phosphorylation | SGSSSNGSSINMSGI CCCCCCCCCCCCCCC | 32.09 | 22468782 | |
638 | Phosphorylation | GSSSNGSSINMSGID CCCCCCCCCCCCCCC | 21.27 | 22210691 | |
650 | Phosphorylation | GIDNGEGTRLRNVPV CCCCCCCCCCCCCCE | 23.41 | 22210691 | |
662 | Phosphorylation | VPVLFNDTETNLAGM CCEEECCCCCCHHHH | 45.90 | 26657352 | |
664 | Phosphorylation | VLFNDTETNLAGMYG EEECCCCCCHHHHHH | 37.31 | 27251275 | |
670 | Phosphorylation | ETNLAGMYGKVRKAA CCCHHHHHHHHHHHH | 16.93 | - | |
672 | Ubiquitination | NLAGMYGKVRKAASS CHHHHHHHHHHHHHC | 22.75 | 32015554 | |
675 | Ubiquitination | GMYGKVRKAASSIDQ HHHHHHHHHHHCCCH | 51.82 | 33845483 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GOGA5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GOGA5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GOGA5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PKN3_HUMAN | PKN3 | physical | 27173435 | |
TFPT_HUMAN | TFPT | physical | 27173435 | |
YETS4_HUMAN | YEATS4 | physical | 27173435 | |
CLOCK_HUMAN | CLOCK | physical | 27173435 | |
PSMD9_HUMAN | PSMD9 | physical | 27173435 | |
VPS50_HUMAN | CCDC132 | physical | 27173435 | |
CAVN1_HUMAN | PTRF | physical | 27173435 | |
HAUS6_HUMAN | HAUS6 | physical | 27173435 | |
RPR1A_HUMAN | RPRD1A | physical | 27173435 | |
BMAL1_HUMAN | ARNTL | physical | 27173435 | |
RABX5_HUMAN | RABGEF1 | physical | 27173435 | |
NUF2_HUMAN | NUF2 | physical | 27173435 | |
EIPR1_HUMAN | TSSC1 | physical | 27173435 | |
STRN_HUMAN | STRN | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
188550 | Thyroid papillary carcinoma (TPC) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-42 AND TYR-54, AND MASSSPECTROMETRY. | |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-42 AND TYR-54, AND MASSSPECTROMETRY. |